证券代码：601319 证券简称： 中国人保 公告编号：临 2025-007 中国人民保险集团股份有限公司 关于召开 2024 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担法律责任。 重要内容提示： 二、 业绩说明会召开的时间、地点 （一）会议召开时间：3 月 28 日（星期五） 15:00-17:00 （二）会议召开方式：现场交流和网络直播 （三）网络直播地址：上证路演中心 （https://roadshow.sseinfo.com/） 三、 参加人员 本公司拟于 2025 年 3 月 27 日在上海证券交易所网站 （www.sse.com.cn）披露本公司 2024 年度报告。为了便于广大投资 者更全面深入地了解本公司 2024 年度业绩和经营情况，本公司拟于 3 月 28 日 15:00-17:00 召开业绩说明会，就投资者普遍关注的问题 进行交流。 会议召开时间：2025 年 3 月 28 日(星期五) 15:00-17:00 会议召开方式：现场交流和网络直播 网络直播地址：上证路演中心（https:/ ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 1339 董事會會議通知 中國人民保險集團股份有限公司 丁向群 董事長 中國北京，二零二五年三月十七日 於本公告日，本公司執行董事為丁向群女士、趙鵬先生及肖建友先生，非執行董事為王 清劍先生、苗福生先生、王少群先生、喻強先生及宋洪軍先生，獨立非執行董事為邵善 波先生、徐麗娜女士、王鵬程先生及高平陽先生。 中國人民保險集團股份有限公司（「本公司」）董事會（「董事會」）茲通告謹定於二零二五年 三月二十七日（星期四）舉行董事會會議，以審議及批准本公司及其附屬公司截至二零二 四年十二月三十一日止年度的全年業績及其刊發，考慮派付末期股息（如有），並處理任 何其他事項。 承董事會命 ...

Investment Rating - The report assigns an "Accumulate" rating for China People's Insurance Company (601319) for the first time [6]. Core Views - China People's Insurance Company is a leading player in the property insurance sector, with a strong focus on both property and life insurance, showing promising transformation results in its life insurance segment [4][14]. - The company has demonstrated stable growth in investment management, with a compound annual growth rate of 8.6% in total investment assets from 2015 to 2023 [3]. - The forecast for revenue growth is 14% in 2024, followed by 6% and 8% in 2025 and 2026, respectively, with a significant expected increase in net profit in 2024 [4]. Summary by Sections Company Overview - China People's Insurance Company has a long-standing history and is recognized as a pioneer in the insurance industry, with a comprehensive business model covering property, life, and health insurance [14][15]. - The company has maintained a dominant position in the property insurance market, with property insurance accounting for over 70% of its revenue [15][16]. Property Insurance - The company leads the market with a property insurance premium market share of 31.8% as of the end of 2024, significantly ahead of its competitors [18]. - The combined operating ratio (COR) for auto insurance is 96.4% in 2024H1, indicating strong underwriting profitability [39]. - Non-auto insurance premiums are expected to be a major growth driver, with a projected share of 44.7% in 2024 [37]. Life Insurance - The new business value (NBV) for life insurance has shown a remarkable recovery, with a year-on-year growth of 69.6% in 2023 and 91% in 2024H1 [2]. - The bank insurance channel has become a significant contributor, accounting for 49.1% of the NBV in 2024H1 [2]. - The health insurance segment has also seen substantial growth, with a 159% increase in NBV in 2024H1 compared to the previous year [2]. Investment Performance - The total investment assets reached 1.53 trillion yuan by the end of 2024H1, with an average net investment return of 5.1% from 2015 to 2024H1, outperforming major competitors [3]. - The company has maintained a stable investment performance with low volatility, contributing positively to its overall profitability [3]. Profit Forecast and Valuation - The company is expected to achieve a revenue growth of 14% in 2024, with net profit projected to increase by 88% [4]. - The target price is set at 7.88 yuan, corresponding to a price-to-book (PB) ratio of 1.21 times for 2025 [4].

Investment Rating - The industry investment rating is "Recommended" [1] Core Insights - The report highlights the rapid expansion of the bancassurance channel, with a significant restructuring of channel dynamics following the integration of insurance and banking operations [4][6] - The insurance sector is expected to benefit from improving macroeconomic policies and a recovering market, which will alleviate investment pressures for insurance companies [6] - The report anticipates a continued growth trend in profits and new business value (NBV) for insurance companies in the first quarter of 2025 [6] Summary by Sections Industry Overview - As of the end of 2023, the insurance industry had a total of 19 listed companies with a total share capital of 2,040.86 million shares, generating sales revenue of 39,503.64 billion CNY and a total profit of 4,107.99 billion CNY [1] Channel Structure - The bancassurance channel's premium income share increased to 36.7%, up by 2.0 percentage points year-on-year, while the personal agency channel's share decreased to 50.9%, down by 2.3 percentage points year-on-year [4] - The bancassurance channel has seen a cumulative increase of 6.4 percentage points since 2019, indicating a strong growth trajectory [4] Product Structure - By the end of 2023, ordinary life insurance accounted for 57.1% of total premium income, an increase of 7.9 percentage points year-on-year, driven by demand for safe investment products [5] - The report notes a decline in the share of participating insurance and health insurance, with participating insurance at 20.5% (down 6.0 percentage points) and health insurance at 20.7% (down 1.6 percentage points) [5] Investment Recommendations - The report maintains a "Recommended" rating for the industry, citing that the average static and dynamic price-to-earnings value (PEV) for four major insurance companies is at historically low levels, indicating limited downside risk [6] - Specific recommendations include strong endorsements for companies like Xinhua Insurance, China Ping An, China Pacific Insurance, and China Life, based on their robust performance and growth potential [6]

Investment Rating - The report maintains a positive outlook on the venture capital and technology sectors, as well as consumer loans, with a favorable view on the brokerage sector's valuation and performance improvement [2]. Core Insights - The government work report for 2025 emphasizes stabilizing the real estate and stock markets, promoting healthy development through innovative monetary policy tools, and enhancing market confidence [1]. - The report highlights the establishment of a national venture capital guidance fund to address fundraising challenges and support technological innovation [1]. - There is an expected recovery in consumer loan demand due to fiscal subsidies for personal consumption loans in key areas [1]. Summary by Sections Securities Sector - The report suggests that the brokerage sector will benefit from improved market activity and confidence due to government support measures [1]. - It identifies four main investment lines within the brokerage sector, including companies with strong technology portfolios and improved exit channels [2]. Insurance Sector - The report notes that insurance funds are expected to have more investment channels, with regulatory support for insurance capital to invest in financial asset investment companies [3][29]. - It mentions that insurance capital has been actively entering the stock market, with net purchases of approximately 290 billion in A-shares since September of the previous year [4]. - The report anticipates significant profit growth in the property and life insurance sectors due to favorable market conditions and low baselines [5]. Market Dynamics - The report indicates that the A-share market has shown an upward trend, with the CSI 300 index increasing by 1.4% [8]. - It provides data on brokerage activities, including a decrease in average daily trading volume and a significant increase in new equity fund issuance [12].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 1339 董事名單與其角色和職能 三、獨立非執行董事 邵善波 徐麗娜 王鵬程 高平陽 - 1 - 一、執行董事 丁向群 （董事長） 趙 鵬 （副董事長） 肖建友 二、非執行董事 王清劍 苗福生 王少群 喻 強 宋洪軍 四、董事會專業委員會 董事會下設五個董事會專業委員會，各董事會專業委員會的組成如下： | | 委員會 | 審計 | 提名薪酬 | 戰略與投資 | 關聯交易 | 風險管理與 消費者權益 | | --- | --- | --- | --- | --- | --- | --- | | 董事 | | 委員會 | 委員會 | 委員會 | 控制委員會 | 保護委員會 | | 丁向群 | | | | C | | | | 趙 鵬 | | | | M | | | | 肖建友 | | | | M | | | | 王清劍 | | M | | M | | | | 苗福生 | | | M | | | M | | 王 ...

中国人民保险集团股份有限公司 关于执行董事、副总裁辞任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 法律责任。 本公司董事会收到李祝用先生的辞呈。因工作调动，李祝用先生 辞去本公司执行董事、副总裁、董事会风险管理与消费者权益保护委 员会主任委员、董事会关联交易控制委员会委员及合规负责人、首席 风险官职务。该辞任自 2025 年 3 月 3 日起生效。李祝用先生已确认 其与本公司董事会、管理层无不同意见，亦没有任何其他事项需要通 知本公司股东。 证券代码：601319 证券简称：中国人保 公告编号：临 2025-006 本公司董事会对李祝用先生在任职期间做出的重要贡献表示衷 心感谢！ 特此公告。 中国人民保险集团股份有限公司董事会 2025 年 3 月 4 日 李祝用先生在担任本公司执行董事、副总裁等职务期间，恪尽职 守，勤勉履职，开拓创新，务实担当，在本公司贯彻落实中央决策部 署、持续完善公司治理、坚守风险合规底线、完成境内外整体上市、 推进高质量发展、建设世界一流保险金融集团等方面发挥了重要作用。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國人民保險集團股份有限公司 呈交日期: 2025年3月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01339 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 8,726,234,000 | RMB | | 1 RMB | | 8,726,234,000 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 8,726,234,000 | RMB | | 1 RMB | | 8,726,234,000 | | 2. 股份分類 | 普通股 | 股份類別 ...

1339 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 三、獨立非執行董事 邵善波 徐麗娜 王鵬程 高平陽 - 1 - 四、董事會專業委員會 董事會下設五個董事會專業委員會，各董事會專業委員會的組成如下： | | | 委員會 | | | | | 風險管理與 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 提名薪酬 | 戰略與投資 | 關聯交易 | 消費者權益 | | 董 | 事 | | 審計委員會 | 委員會 | 委員會 | 控制委員會 | 保護委員會 | | 丁向群 | | | | | C | | | | 趙 | 鵬 | | | | M | | | | 李祝用 | | | | | | M | C | | 肖建友 | | | | | M | | | | 王清劍 | | | M | | M | | | | 苗福生 | | | | M | | | M | | 王少群 | | | ...

证券代码：601319 证券简称：中国人保 公告编号：临 2025-005 本公司董事会对高永文先生在任职期间勤勉尽职的工作和对本 公司作出的贡献表示衷心感谢，亦欢迎高平阳先生加入董事会。 特此公告。 中国人民保险集团股份有限公司 关于独立董事任职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 法律责任。 根据 2024 年 4 月 29 日中国人民保险集团股份有限公司（以下简 称"本公司"）第四届董事会第二十五次会议决议，高平阳先生担任 本公司独立董事的任期，自股东大会审议通过其担任公司独立董事且 其独立董事任职资格获得国家金融监督管理总局核准之日起算。 本公司于 2024 年 6 月 28 日召开 2023 年度股东大会，选举高平 阳先生为本公司第五届董事会独立董事。 本公司近日收到《国家金融监督管理总局关于高平阳中国人民保 险集团股份有限公司独立董事任职资格的批复》（金复〔2025〕76 号）。 根据上述批复，国家金融监督管理总局已核准高平阳先生担任本公司 独立董事的任职资格。高先生担任本公司独立董事的任职自 2025 年 ...